ADVERTISEMENT

Comments?
Help us improve Portfolio Grader.


Comments?
Help us improve Portfolio Grader.


Blue Chip Growth

Stock Report: HeartWare International Inc (HTWR) Report Updated: May 20, 2013 | Print This Page

Get more stock ratings by Louis Navellier

HeartWare International Inc (HTWR)

Rating: Sell Volatility: Conservative
Total Grade: D Industry: Health Care Equipment & Supplies
Competitors: SRDX, GNMK, NVDQ, WST
hide

Stock Analysis

Rating: Monthly View

A
B
C
D
F
May June July August September October November December January February March April

Rating: Weekly View

This Week: D down downgrade
Last Week: C same no change
Two Weeks Ago: C up upgrade
service keys
hide

HeartWare International Inc© quotemedia

hide

Company Profile

HeartWare International, Inc., a medical device company, develops and manufactures miniaturized implantable heart pumps or ventricular assist devices (VAD) for the treatment of advanced heart failure in the United States and internationally. The company offers HeartWare Ventricular Assist System, which includes a VAD, or blood pump, patient accessories, and surgical tools designed to provide circulatory support for patients in the advanced stage of heart failure. It is also developing the MVAD, a miniaturized blood pump, intended for chronic heart failure patients. HeartWare International, Inc. markets its products directly to cardiac centers and hospitals, as well as through medical device distributors. The company is headquartered in Framingham, Massachusetts.